he 5th APHOG–SIOP Asia Joint Scientific Symposium will take place on Wednesday, 5 November 2025, bringing together experts from across the region and beyond to discuss the latest advances in Juvenile Myelomonocytic Leukaemia (JMML) and Myelodysplastic Syndromes (MDS).

This virtual symposium, jointly organised by the Asian Pediatric Hematology Oncology Group (APHOG) and SIOP Asia, will feature world-renowned speakers sharing cutting-edge insights on molecular genetics, clinical trials, and transplantation approaches shaping the future of JMML and MDS care.

Time:
06:00–08:00 (EST, USA) | 16:30–18:30 (IST, India) | 20:00–22:00 (JST, Japan)

Programme Highlights:

• Opening Remarks: Akira Nakagawara (APHOG) and Gevorg Tamamyan (SIOP Asia, APHOG)

• Moderators: Godfrey Chan (Hong Kong, China), Yongmin Tang (China), and Bharat Agarwal (India)

• Speakers:

  • Charlotte Niemeyer (Germany) — How molecular genetics shaped the diagnosis and treatment of JMML

  • Hideki Muramatsu (Japan) — Molecular Pathogenesis of JMML and the Planned Clinical Trial of Azacitidine Plus Trametinib

  • Kirill Kirgizov (Russia) — Hematopoietic stem cell transplantation in JMML

  • Xiaofan Zhu (China) — Pediatric myelodysplastic syndromes

  • Henrik Hasle (Denmark) — MDS in children

• Summary: Atsushi Manabe (JCCG, Japan)

• Closing Remarks: Hiroki Hori (Immediate Past-President, SIOP Asia)

This two-hour session promises rich scientific discussion and collaboration among paediatric haematology–oncology professionals committed to advancing care and research in these rare but challenging diseases.